Institutional investors hold a majority ownership of JNJ through the 69.71% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AMUNDI ASSET MANAGEMENT US, INC. Bought 4.2 Million shares of Johnson & Johnson
THE VANGUARD GROUP, INC. Bought 2.2 Million shares of Johnson & Johnson
TEMPLETON GLOBAL ADVISORS LTD. Bought 2.2 Million shares of Johnson & Johnson